Conditional Loan of Up to $500 Million Cuts C.H. Robinson’s RXO Acquisition Bridge Facility
Key Facts
On November 19, 2026, C.H. Robinson entered into an unsecured delayed-draw term loan agreement of up to $500 million to finance part of its announced acquisition of RXO, related transactions, fees and expenses. The company disclosed the agreement in a filing with the U.S. Securities and Exchange Commission, stating that the amount represents the maximum available under it. Signing the agreement does not mean the company has drawn the loan; funding is subject to specified conditions. Its most immediate effect is to reduce commitments under the 364-day unsecured bridge facility by $500 million. This forms part of the deal’s financing arrangements, and management said the same day that the expected closing timeline in the first half of 2027 remains in place.
Interest is set according to the company’s option and credit rating: it may be at Term SOFR plus a margin of between 0.75% and 1.375%, or at the base rate plus a margin of between 0% and 0.375%. The agreement also imposes an annual fee on undrawn commitments ranging from 0.07% to 0.15%. That fee begins accruing on the later of the agreement’s effective date or February 1, 2027. The potential cost of the facility therefore includes borrowing costs when drawn and a fee on the available portion that remains unused. Any draw remains largely tied to completion of the acquisition in accordance with the merger agreement and satisfaction of other conditions.
The agreement sets net leverage limits, linking the financing to the company’s debt level after funding. The ratio may not exceed 4.25 to 1.00 during the first four fiscal quarters after funding, then the limit falls to 3.75 to 1.00. The covenant includes a specified exception for permitted acquisitions, according to the company’s disclosure. Financing conditions also include delivery of a solvency certificate and repayment of RXO’s existing asset-based credit facility. They also require that no material adverse effect occur with respect to RXO, along with satisfaction of the other conditions set out in the agreement.
Alongside the loan, C.H. Robinson amended its receivables securitization facility, bringing commitments after the amendment to $300 million from Bank of America and $450 million from Wells Fargo. Total committed financing under the facility is $750 million. The scheduled purchase termination date was also extended to November 17, 2028. The amendment adds a receivables-linked financing arrangement alongside the new loan and the bridge facility. The disclosures show that the new loan agreement was accompanied by an equal reduction in bridge commitments, while the receivables facilities remained at the stated amounts and revised date.
The implied value of the acquisition was estimated at about $5.8 billion when it was announced. The basic consideration for RXO shareholders is $17.25 in cash and 0.0856 C.H. Robinson shares for each RXO share, equivalent to $30.25 per share based on C.H. Robinson’s specified average share price through October 2, 2026. The company said it is targeting about $300 million in ongoing annual cost savings within two years of closing the deal. The opportunities it cited include lower cost to serve and integration benefits. Achieving those savings remains dependent on closing the deal and the timeline announced by management.
C.H. Robinson management said on November 19 that the expected first-half 2027 closing timeline “remains largely in place,” noting that it had resubmitted its filing to the U.S. government to allow additional time for review. The deal requires approval from RXO shareholders and regulators. RXO warned that regulatory approvals may not be granted or may take longer than expected. Authorities may also impose conditions that delay the deal or adversely affect the combined company and the expected benefits. The loan therefore remains conditional on completion of the acquisition and satisfaction of the agreement’s requirements, while the targeted closing date remains in the first half of 2027.